Hana Biosciences, Inc.
Company initiates phase I/II clinical trial of talotrexin in patients with ALL
Published in Health Business Week, June 10th, 2005
The phase I portion of this multicenter study will determine the dose, safety, tolerability, and pharmacokinetics of talotrexin in refractory leukemia patients, including both myeloid and lymphoid leukemias. The phase II component will focus on relapsed or refractory ALL patients to determine the efficacy of talotrexin, as measured by complete response rate.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2005-06-10)
More Articles from Health Business Week
- AMS Health Sciences, Inc.
Sales increase in April for nutritional supplements company - Alliance Medical Corporation
Device reprocessor selected by Cooperative Services of Florida - Alltracel Pharmaceuticals Plc.
Nanotechnology development partnership signed for woundcare applications - Ambit Biosciences
Biopharmaceutical company raises $31M in series C financing - Arrhythmia Research Technology, Inc.
Medical device company reports income per share of $0.16 - AspenBio, Inc.
Hormone manufacturer closes on $3,072,642 private placement - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
